(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABCG5 mRNA] CTD PMID:31150632 1,2,3-trilinolenoylglycerol decreases expression ISO RGD:732220 6480464 trilinolenin results in decreased expression of ABCG5 mRNA CTD PMID:18356535 1,2,3-trilinoleoylglycerol decreases expression ISO RGD:732220 6480464 trilinolein results in decreased expression of ABCG5 mRNA CTD PMID:18356535 1,2-dichloroethane decreases expression ISO RGD:732220 6480464 ethylene dichloride results in decreased expression of ABCG5 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:732220 6480464 1, 2-Dimethylhydrazine results in decreased expression of ABCG5 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of ABCG5 mRNA CTD PMID:25380136 more ... 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ABCG5 mRNA CTD PMID:27765674 1-naphthyl isothiocyanate decreases expression ISO RGD:732220 6480464 1-Naphthylisothiocyanate results in decreased expression of ABCG5 mRNA CTD PMID:28549656 1-naphthyl isothiocyanate multiple interactions ISO RGD:732220 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCG5 mRNA] CTD PMID:28549656 1-naphthyl isothiocyanate multiple interactions ISO RGD:732219 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ABCG5 mRNA CTD PMID:27344345 17alpha-ethynylestradiol multiple interactions ISO RGD:732220 6480464 ESR1 protein promotes the reaction [Ethinyl Estradiol results in decreased expression of ABCG5 mRNA] CTD PMID:16606610 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of ABCG5 mRNA CTD PMID:26865667 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of ABCG5 mRNA CTD PMID:12963437 more ... 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with Diosgenin] results in decreased expression of ABCG5 mRNA, [Ethinyl Estradiol results in decreased expression of ABCG5 mRNA] which results in decreased secretion of Cholesterol CTD PMID:12963437 , PMID:16105132 17alpha-ethynylestradiol decreases expression ISO RGD:732220 6480464 Ethinyl Estradiol results in decreased expression of ABCG5 mRNA CTD PMID:16606610 17beta-estradiol decreases expression ISO RGD:732219 6480464 Estradiol results in decreased expression of ABCG5 mRNA CTD PMID:20106945 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of ABCG5 mRNA, [Testosterone co-treated with Estradiol] results in increased expression of ABCG5 mRNA CTD PMID:26496021 , PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:732220 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:32679240 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:732220 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732220 6480464 [AHR gene mutant form affects the susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ABCG5 mRNA more ... CTD PMID:21846477 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732220 6480464 Tetrachlorodibenzodioxin results in decreased expression of ABCG5 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732220 6480464 Tetrachlorodibenzodioxin results in increased expression of ABCG5 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732219 6480464 Tetrachlorodibenzodioxin results in decreased expression of ABCG5 mRNA CTD PMID:20106945 , PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732220 6480464 Tetrachlorodibenzodioxin affects the expression of ABCG5 mRNA CTD PMID:21570461 , PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ABCG5 mRNA CTD PMID:21215274 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ABCG5 mRNA CTD PMID:21346803 3,3',5-triiodo-L-thyronine multiple interactions EXP 6480464 [BMS201038 co-treated with Triiodothyronine] results in increased expression of ABCG5 mRNA CTD PMID:34902352 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of ABCG5 mRNA CTD PMID:34902352 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of ABCG5 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol decreases expression ISO RGD:732220 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of ABCG5 mRNA CTD PMID:30951980 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of ABCG5 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of ABCG5 mRNA CTD PMID:19483382 7-ketocholesterol decreases expression ISO RGD:732219 6480464 7-ketocholesterol results in decreased expression of ABCG5 mRNA CTD PMID:23454145 7-ketocholesterol multiple interactions ISO RGD:732219 6480464 [7-ketocholesterol co-treated with KNG1 protein modified form] results in decreased expression of ABCG5 mRNA more ... CTD PMID:23454145 aflatoxin B1 affects expression ISO RGD:732219 6480464 Aflatoxin B1 affects the expression of ABCG5 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:732219 6480464 Aflatoxin B1 results in decreased methylation of ABCG5 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:732219 6480464 Aflatoxin B1 results in decreased expression of ABCG5 mRNA CTD PMID:27153756 , PMID:32234424 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ABCG5 mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin B1 increases expression ISO RGD:732220 6480464 Aflatoxin B1 results in increased expression of ABCG5 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:732219 6480464 Tretinoin results in decreased expression of ABCG5 mRNA CTD PMID:30709899 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of ABCG5 mRNA CTD PMID:19483382 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of ABCG5 mRNA CTD PMID:27765674 amitriptyline decreases expression EXP 6480464 Amitriptyline results in decreased expression of ABCG5 mRNA CTD PMID:27765674 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ABCG5 mRNA CTD PMID:16483693 androst-4-ene-3,17-dione multiple interactions ISO RGD:732219 6480464 Androstenedione results in increased activity of [ABCG5 protein binds to ABCG8 protein] CTD PMID:17055487 arsane affects methylation ISO RGD:732219 6480464 Arsenic affects the methylation of ABCG5 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:732219 6480464 Arsenic affects the methylation of ABCG5 gene CTD PMID:25304211 atazanavir sulfate multiple interactions ISO RGD:732219 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ABCG5 mRNA CTD PMID:33819548 atorvastatin calcium increases expression ISO RGD:732220 6480464 Atorvastatin results in increased expression of ABCG5 mRNA CTD PMID:25278499 azathioprine decreases expression EXP 6480464 Azathioprine results in decreased expression of ABCG5 mRNA CTD PMID:27765674 aztreonam increases expression ISO RGD:732220 6480464 Aztreonam results in increased expression of ABCG5 mRNA CTD PMID:24657338 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of ABCG5 mRNA CTD PMID:19483382 benzo[a]pyrene increases expression ISO RGD:732220 6480464 Benzo(a)pyrene results in increased expression of ABCG5 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:732219 6480464 Benzo(a)pyrene results in decreased expression of ABCG5 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:732219 6480464 Benzo(a)pyrene results in decreased methylation of ABCG5 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:732220 6480464 Benzo(a)pyrene results in decreased expression of ABCG5 mRNA CTD PMID:22228805 bezafibrate increases expression ISO RGD:732219 6480464 Bezafibrate results in increased expression of ABCG5 mRNA CTD PMID:14685799 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:732220 6480464 [APOE gene mutant form results in increased susceptibility to Diethylhexyl Phthalate] which results in decreased expression of ABCG5 protein CTD PMID:25270622 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of ABCG5 mRNA CTD PMID:26496021 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ABCG5 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A affects expression ISO RGD:732220 6480464 bisphenol A affects the expression of ABCG5 mRNA CTD PMID:27502578 bosentan increases expression EXP 6480464 bosentan results in increased expression of ABCG5 mRNA CTD PMID:27765674 bosentan affects expression ISO RGD:732219 6480464 Bosentan affects the expression of ABCG5 mRNA CTD PMID:29761207 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of ABCG5 mRNA CTD PMID:22110744 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of ABCG5 promoter CTD PMID:22457795 carbon nanotube decreases expression ISO RGD:732220 6480464 Nanotubes, Carbon results in decreased expression of ABCG5 mRNA CTD PMID:25620056 carmustine affects response to substance ISO RGD:732219 6480464 ABCG5 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chenodeoxycholic acid increases expression ISO RGD:732219 6480464 Chenodeoxycholic Acid results in increased expression of ABCG5 mRNA CTD PMID:25055961 , PMID:27174168 chenodeoxycholic acid multiple interactions ISO RGD:732219 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ABCG5 mRNA more ... CTD PMID:33819548 chenodeoxycholic acid increases expression ISO RGD:732220 6480464 Chenodeoxycholic Acid results in increased expression of ABCG5 mRNA CTD PMID:25582706 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of ABCG5 mRNA CTD PMID:30744511 cholate multiple interactions ISO RGD:732220 6480464 Cholates promotes the reaction [ABCG5 protein results in increased secretion of Cholesterol] CTD PMID:15611112 cholate increases expression ISO RGD:732220 6480464 Cholates results in increased expression of ABCG5 mRNA, Cholates results in increased expression of ABCG5 protein CTD PMID:15611112 cholesterol affects export ISO RGD:732219 6480464 ABCG5 protein affects the export of Cholesterol CTD PMID:15696852 cholesterol multiple interactions EXP 6480464 [Diosgenin results in increased expression of ABCG5 mRNA] which results in increased secretion of Cholesterol, [Ethinyl Estradiol results in decreased expression of ABCG5 mRNA] which results in decreased secretion of Cholesterol CTD PMID:12963437 cholesterol increases expression EXP 6480464 Cholesterol results in increased expression of ABCG5 mRNA CTD PMID:15683829 cholesterol decreases expression EXP 6480464 Cholesterol results in decreased expression of ABCG5 mRNA CTD PMID:15683829 cholesterol increases expression ISO RGD:732220 6480464 Cholesterol results in increased expression of ABCG5 mRNA CTD PMID:15683829 cholesterol multiple interactions ISO RGD:732220 6480464 [Cholesterol deficiency co-treated with Dietary Fats] results in decreased expression of ABCG5 mRNA more ... CTD PMID:15611112 , PMID:18356535 cholesterol increases secretion ISO RGD:732220 6480464 ABCG5 protein results in increased secretion of Cholesterol CTD PMID:15611112 cholic acid increases expression ISO RGD:732219 6480464 Cholic Acid results in increased expression of ABCG5 mRNA CTD PMID:25055961 cholic acid multiple interactions ISO RGD:732220 6480464 [NR1H4 protein mutant form inhibits the reaction [Cholic Acid results in increased phosphorylation of NR1H4 protein]] which results in decreased expression of ABCG5 mRNA CTD PMID:30996006 cholic acid increases expression ISO RGD:732220 6480464 Cholic Acid results in increased expression of ABCG5 mRNA CTD PMID:25582706 chromium(6+) affects expression ISO RGD:732220 6480464 chromium hexavalent ion affects the expression of ABCG5 mRNA CTD PMID:28472532 clavulanic acid decreases expression ISO RGD:732219 6480464 Clavulanic Acid results in decreased expression of ABCG5 mRNA CTD PMID:34767876 clavulanic acid multiple interactions ISO RGD:732219 6480464 Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ABCG5 mRNA], GW 4064 inhibits the reaction [Clavulanic Acid results in decreased expression of ABCG5 mRNA] CTD PMID:34767876 clofibrate decreases expression ISO RGD:732220 6480464 Clofibrate results in decreased expression of ABCG5 mRNA CTD PMID:28973556 clofibrate multiple interactions ISO RGD:732220 6480464 Clofibrate inhibits the reaction [PPARA gene mutant form results in increased expression of ABCG5 mRNA] CTD PMID:29175453 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of ABCG5 mRNA CTD PMID:12851107 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of ABCG5 mRNA CTD PMID:19483382 clofibrate increases expression ISO RGD:732220 6480464 Clofibrate results in increased expression of ABCG5 mRNA CTD PMID:22496397 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCG5 mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ABCG5 mRNA CTD PMID:24386269 copper(II) sulfate decreases expression ISO RGD:732219 6480464 Copper Sulfate results in decreased expression of ABCG5 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ABCG5 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:732219 6480464 Cyclosporine results in decreased expression of ABCG5 mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions ISO RGD:732219 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ABCG5 mRNA CTD PMID:33819548 dehydroepiandrosterone multiple interactions ISO RGD:732219 6480464 Dehydroepiandrosterone results in increased activity of [ABCG5 protein binds to ABCG8 protein] CTD PMID:17055487 deoxycholic acid increases expression ISO RGD:732219 6480464 Deoxycholic Acid results in increased expression of ABCG5 mRNA CTD PMID:25055961 deoxycholic acid multiple interactions ISO RGD:732219 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ABCG5 mRNA more ... CTD PMID:33819548 deoxycholic acid increases expression ISO RGD:732220 6480464 Deoxycholic Acid results in increased expression of ABCG5 mRNA CTD PMID:21914718 , PMID:25582706 deoxycholic acid multiple interactions ISO RGD:732220 6480464 SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid results in increased expression of ABCG5 mRNA] CTD PMID:21914718 dibenz[a,h]anthracene increases expression ISO RGD:732220 6480464 1 more ... CTD PMID:26377693 dichloroacetic acid increases expression ISO RGD:732220 6480464 Dichloroacetic Acid results in increased expression of ABCG5 mRNA CTD PMID:28962523 diosgenin multiple interactions ISO RGD:732220 6480464 Diosgenin promotes the reaction [ABCG5 protein results in increased secretion of Cholesterol] CTD PMID:15611112 diosgenin increases expression EXP 6480464 Diosgenin results in increased expression of ABCG5 mRNA CTD PMID:12963437 diosgenin multiple interactions EXP 6480464 [Diosgenin results in increased expression of ABCG5 mRNA] which results in increased secretion of Cholesterol, [Ethinyl Estradiol co-treated with Diosgenin] results in decreased expression of ABCG5 mRNA CTD PMID:12963437 , PMID:16105132 doxycycline increases expression EXP 6480464 Doxycycline results in increased expression of ABCG5 mRNA CTD PMID:27765674 epoxiconazole decreases expression ISO RGD:732220 6480464 epoxiconazole results in decreased expression of ABCG5 mRNA CTD PMID:35436446 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of ABCG5 mRNA CTD PMID:24412560 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of ABCG5 mRNA CTD PMID:27765674 fipronil increases expression ISO RGD:732220 6480464 fipronil results in increased expression of ABCG5 mRNA CTD PMID:23962444 fipronil increases expression EXP 6480464 fipronil results in increased expression of ABCG5 mRNA CTD PMID:23962444 furan increases expression EXP 6480464 furan results in increased expression of ABCG5 mRNA CTD PMID:25539665 , PMID:26194646 genistein decreases expression ISO RGD:732219 6480464 Genistein results in decreased expression of ABCG5 mRNA CTD PMID:26865667 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of ABCG5 mRNA CTD PMID:24136188 glyburide increases expression EXP 6480464 Glyburide results in increased expression of ABCG5 mRNA CTD PMID:27765674 glycochenodeoxycholic acid multiple interactions ISO RGD:732219 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ABCG5 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO RGD:732219 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ABCG5 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:732219 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ABCG5 mRNA more ... CTD PMID:33819548 glycyrrhetinate multiple interactions ISO RGD:732220 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCG5 mRNA] CTD PMID:28549656 glycyrrhetinic acid multiple interactions ISO RGD:732220 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCG5 mRNA] CTD PMID:28549656 guggulsterone decreases expression ISO RGD:732219 6480464 pregna-4 more ... CTD PMID:34767876 guggulsterone multiple interactions ISO RGD:732219 6480464 GW 4064 inhibits the reaction [pregna-4 more ... CTD PMID:34767876 GW 3965 increases expression ISO RGD:732220 6480464 GW 3965 results in increased expression of ABCG5 mRNA CTD PMID:15633131 GW 4064 multiple interactions ISO RGD:732220 6480464 FGF15 gene mutant form inhibits the reaction [GW 4064 results in increased expression of ABCG5 mRNA], NR1H4 gene mutant form inhibits the reaction [GW 4064 results in increased expression of ABCG5 mRNA] CTD PMID:22918042 , PMID:30996006 GW 4064 increases expression ISO RGD:732219 6480464 GW 4064 results in increased expression of ABCG5 mRNA CTD PMID:34767876 GW 4064 multiple interactions ISO RGD:732219 6480464 Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ABCG5 mRNA] more ... CTD PMID:34767876 GW 4064 increases expression ISO RGD:732220 6480464 GW 4064 results in increased expression of ABCG5 mRNA CTD PMID:22918042 , PMID:30996006 imipenem hydrate multiple interactions ISO RGD:732220 6480464 [Vancomycin co-treated with Imipenem] affects the expression of ABCG5 mRNA CTD PMID:24657338 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of ABCG5 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG5 mRNA CTD PMID:22129741 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of ABCG5 mRNA CTD PMID:19483382 leflunomide decreases expression ISO RGD:732219 6480464 leflunomide results in decreased expression of ABCG5 mRNA CTD PMID:28988120 lipopolysaccharide decreases expression ISO RGD:732220 6480464 Lipopolysaccharides results in decreased expression of ABCG5 mRNA CTD PMID:15312237 lithocholic acid increases expression ISO RGD:732219 6480464 Lithocholic Acid results in increased expression of ABCG5 mRNA CTD PMID:25055961 lithocholic acid increases expression ISO RGD:732220 6480464 Lithocholic Acid results in increased expression of ABCG5 mRNA CTD PMID:25582706 lithocholic acid multiple interactions ISO RGD:732220 6480464 [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in increased expression of ABCG5 mRNA CTD PMID:20359477 lovastatin affects expression ISO RGD:732220 6480464 Lovastatin affects the expression of ABCG5 mRNA CTD PMID:27208389 lovastatin multiple interactions ISO RGD:732220 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of ABCG5 mRNA CTD PMID:29852127 metformin decreases expression EXP 6480464 Metformin results in decreased expression of ABCG5 mRNA CTD PMID:27765674 metformin increases expression EXP 6480464 Metformin results in increased expression of ABCG5 mRNA CTD PMID:31324951 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of ABCG5 mRNA CTD PMID:30744511 methyltestosterone multiple interactions ISO RGD:732219 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of ABCG5 mRNA CTD PMID:27344345 mirex increases expression EXP 6480464 Mirex results in increased expression of ABCG5 mRNA CTD PMID:23153324 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of ABCG5 mRNA CTD PMID:21515302 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of ABCG5 gene CTD PMID:16495775 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCG5 mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG5 mRNA CTD PMID:17602206 , PMID:22129741 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of ABCG5 mRNA CTD PMID:25380136 N-Nitrosopyrrolidine decreases expression ISO RGD:732219 6480464 N-Nitrosopyrrolidine results in decreased expression of ABCG5 mRNA CTD PMID:32234424 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of ABCG5 mRNA CTD PMID:24136188 nefazodone multiple interactions ISO RGD:732219 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ABCG5 mRNA CTD PMID:33819548 O-methyleugenol decreases expression ISO RGD:732219 6480464 methyleugenol results in decreased expression of ABCG5 mRNA CTD PMID:32234424 oltipraz multiple interactions ISO RGD:732220 6480464 [oltipraz co-treated with NFE2L2 protein mutant form] affects the expression of ABCG5 mRNA CTD PMID:22496397 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of ABCG5 mRNA CTD PMID:19483382 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of ABCG5 mRNA CTD PMID:23439660 paracetamol decreases expression ISO RGD:732219 6480464 Acetaminophen results in decreased expression of ABCG5 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol multiple interactions ISO RGD:732219 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ABCG5 mRNA CTD PMID:33819548 PCB138 multiple interactions ISO RGD:732220 6480464 [2 more ... CTD PMID:25510870 perfluorohexanesulfonic acid decreases expression ISO RGD:732220 6480464 perfluorohexanesulfonic acid results in decreased expression of ABCG5 mRNA CTD PMID:21705711 perfluorononanoic acid decreases expression ISO RGD:732219 6480464 perfluoro-n-nonanoic acid results in decreased expression of ABCG5 mRNA CTD PMID:32588087 perfluorononanoic acid increases expression ISO RGD:732220 6480464 perfluoro-n-nonanoic acid results in increased expression of ABCG5 mRNA CTD PMID:29112762 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:732220 6480464 perfluorooctane sulfonic acid results in decreased expression of ABCG5 mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:732219 6480464 perfluorooctane sulfonic acid results in decreased expression of ABCG5 mRNA CTD PMID:27153767 , PMID:32253466 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of ABCG5 mRNA CTD PMID:21723365 perfluorooctanoic acid decreases expression ISO RGD:732220 6480464 perfluorooctanoic acid results in decreased expression of ABCG5 mRNA CTD PMID:17681415 , PMID:30657992 perfluorooctanoic acid decreases expression ISO RGD:732219 6480464 perfluorooctanoic acid results in decreased expression of ABCG5 mRNA CTD PMID:32253466 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ABCG5 mRNA CTD PMID:21723365 perhexiline decreases expression EXP 6480464 Perhexiline results in decreased expression of ABCG5 mRNA CTD PMID:27765674 phenformin increases expression EXP 6480464 Phenformin results in increased expression of ABCG5 mRNA CTD PMID:31324951 phenobarbital increases expression ISO RGD:732220 6480464 Phenobarbital results in increased expression of ABCG5 mRNA CTD PMID:19270015 phenobarbital affects expression ISO RGD:732220 6480464 Phenobarbital affects the expression of ABCG5 mRNA CTD PMID:23091169 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of ABCG5 mRNA CTD PMID:19483382 potassium dichromate increases expression ISO RGD:732220 6480464 Potassium Dichromate results in increased expression of ABCG5 mRNA CTD PMID:23608068 pravastatin increases expression EXP 6480464 Pravastatin results in increased expression of ABCG5 mRNA CTD PMID:15242490 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of ABCG5 mRNA CTD PMID:15683829 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:732220 6480464 Pregnenolone Carbonitrile results in increased expression of ABCG5 mRNA CTD PMID:20359477 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:732220 6480464 [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in increased expression of ABCG5 mRNA CTD PMID:20359477 progesterone multiple interactions ISO RGD:732219 6480464 Progesterone results in decreased activity of [ABCG5 protein binds to ABCG8 protein] CTD PMID:17055487 propanal decreases expression ISO RGD:732219 6480464 propionaldehyde results in decreased expression of ABCG5 mRNA CTD PMID:26079696 propiconazole decreases expression ISO RGD:732220 6480464 propiconazole results in decreased expression of ABCG5 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:732219 6480464 Quercetin results in decreased expression of ABCG5 mRNA CTD PMID:21632981 quercetin multiple interactions ISO RGD:732220 6480464 Quercetin inhibits the reaction [Dietary Fats results in decreased expression of ABCG5 protein], Quercetin inhibits the reaction [Dietary Fats results in increased expression of ABCG5 mRNA] CTD PMID:22447684 quinolin-8-ol decreases expression ISO RGD:732219 6480464 Oxyquinoline results in decreased expression of ABCG5 mRNA CTD PMID:21632981 rotenone multiple interactions ISO RGD:732219 6480464 [7-ketocholesterol co-treated with Rotenone] results in decreased expression of ABCG5 mRNA, [Stigmasterol co-treated with Rotenone] results in decreased expression of ABCG5 mRNA CTD PMID:23454145 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ABCG5 mRNA CTD PMID:27979718 , PMID:28374803 simvastatin increases expression ISO RGD:732220 6480464 Simvastatin results in increased expression of ABCG5 mRNA CTD PMID:21241519 sodium arsenite decreases expression ISO RGD:732220 6480464 sodium arsenite results in decreased expression of ABCG5 mRNA CTD PMID:31532247 sodium arsenite decreases expression ISO RGD:732219 6480464 sodium arsenite results in decreased expression of ABCG5 mRNA CTD PMID:29301061 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of ABCG5 mRNA CTD PMID:22110744 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of ABCG5 mRNA CTD PMID:25993096 sodium fluoride decreases expression ISO RGD:732220 6480464 Sodium Fluoride results in decreased expression of ABCG5 mRNA CTD PMID:27862939 spironolactone decreases expression EXP 6480464 Spironolactone results in decreased expression of ABCG5 mRNA CTD PMID:15683829 stigmasterol decreases expression ISO RGD:732219 6480464 Stigmasterol results in decreased expression of ABCG5 mRNA CTD PMID:23454145 stigmasterol multiple interactions ISO RGD:732219 6480464 [Stigmasterol co-treated with KNG1 protein modified form] results in decreased expression of ABCG5 mRNA more ... CTD PMID:23454145 streptozocin increases expression ISO RGD:732220 6480464 Streptozocin results in increased expression of ABCG5 mRNA CTD PMID:23319174 sulforaphane decreases expression ISO RGD:732219 6480464 sulforaphane results in decreased expression of ABCG5 mRNA CTD PMID:34767876 tamoxifen increases expression ISO RGD:732220 6480464 Tamoxifen results in increased expression of ABCG5 mRNA CTD PMID:25123088 tartrazine multiple interactions ISO RGD:732219 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG5 mRNA CTD PMID:33819548 tebuconazole decreases expression ISO RGD:732219 6480464 tebuconazole results in decreased expression of ABCG5 mRNA CTD PMID:30458266 temozolomide affects response to substance ISO RGD:732219 6480464 ABCG5 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of ABCG5 mRNA CTD PMID:21515302 testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Estradiol] results in increased expression of ABCG5 mRNA CTD PMID:32741896 tetrachloroethene increases expression ISO RGD:732220 6480464 Tetrachloroethylene results in increased expression of ABCG5 mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO RGD:732220 6480464 Carbon Tetrachloride results in decreased expression of ABCG5 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ABCG5 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABCG5 mRNA] CTD PMID:31150632 tetracycline decreases expression ISO RGD:732220 6480464 Tetracycline results in decreased expression of ABCG5 mRNA CTD PMID:24489787 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of ABCG5 mRNA CTD PMID:27765674 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of ABCG5 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ABCG5 mRNA CTD PMID:34492290 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ABCG5 mRNA CTD PMID:23411599 tianeptine increases expression EXP 6480464 tianeptine results in increased expression of ABCG5 mRNA CTD PMID:27765674 toluene affects expression EXP 6480464 Toluene affects the expression of ABCG5 mRNA CTD PMID:18653662 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of ABCG5 mRNA CTD PMID:19409404 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ABCG5 mRNA CTD PMID:33387578 triolein decreases expression ISO RGD:732220 6480464 Triolein results in decreased expression of ABCG5 mRNA CTD PMID:18356535 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of ABCG5 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:732220 6480464 triptonide results in increased expression of ABCG5 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of ABCG5 mRNA CTD PMID:21515302 troglitazone increases expression ISO RGD:732220 6480464 troglitazone results in increased expression of ABCG5 mRNA CTD PMID:28973697 urethane decreases expression ISO RGD:732219 6480464 Urethane results in decreased expression of ABCG5 mRNA CTD PMID:28818685 ursodeoxycholic acid increases expression ISO RGD:732220 6480464 Ursodeoxycholic Acid results in increased expression of ABCG5 mRNA CTD PMID:25582706 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of ABCG5 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:732219 6480464 Valproic Acid results in decreased expression of ABCG5 mRNA CTD PMID:29154799 , PMID:29501571 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ABCG5 mRNA CTD PMID:27765674 vancomycin multiple interactions ISO RGD:732220 6480464 [Vancomycin co-treated with Imipenem] affects the expression of ABCG5 mRNA CTD PMID:24657338 zinc atom decreases expression ISO RGD:732219 6480464 Zinc deficiency results in decreased expression of ABCG5 mRNA CTD PMID:18356318 zinc(0) decreases expression ISO RGD:732219 6480464 Zinc deficiency results in decreased expression of ABCG5 mRNA CTD PMID:18356318